Integrative Genomics in Combination with RNA Interference Identifies Prognostic and Functionally Relevant Gene Targets for Oral Squamous Cell Carcinoma

PLoS Genetics

Volumn 9, Issue 1, 2013, Pages

  Xu, Chang ^a,b   Wang, Pei ^b,c   Liu, Yan ^b   Zhang, Yuzheng ^b   Fan, Wenhong ^b   Upton, Melissa P ^c   Lohavanichbutr, Pawadee ^b   Houck, John R ^b   Doody, David R ^b   Futran, Neal D ^a   Zhao, Lue Ping ^b,c   Schwartz, Stephen M ^b,c   Chen, Chu ^a,b,c   Méndez, Eduardo ^a,b,d  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DNA; RNA; SMALL INTERFERING RNA;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER MORTALITY; CANCER PROGNOSIS; CANCER STAGING; CARCINOMA CELL; CELL SURVIVAL; CONTROLLED STUDY; COPY NUMBER VARIATION; DNA DETERMINATION; FEMALE; G3BP1 GENE; GENE; GENE AMPLIFICATION; GENE CONTROL; GENE DOSAGE; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE SILENCING; GENE TARGETING; GENETIC CORRELATION; GENETIC SCREENING; GENETIC VARIABILITY; GENOMICS; HAZARD RATIO; HETEROZYGOTE; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN TISSUE; LASER MICRODISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; MOUTH SQUAMOUS CELL CARCINOMA; NUCLEOTIDE SEQUENCE; OVERALL SURVIVAL; PRIMARY TUMOR; RNA ANALYSIS; RNA INTERFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR DIFFERENTIATION;

AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOMICS; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM STAGING; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RNA, SMALL INTERFERING;

EID: 84873521122     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1003169     Document Type: Article

References (50)

1. Garzino-Demo P, Dell'Acqua A, Dalmasso P, Fasolis M, Terra Maggiore GM, et al. (2006) Clinicopathological parameters and outcome of 245 patients operated for oral squamous cell carcinoma. Journal of Cranio-Maxillo-Facial Surgery 34: 344-350.
2. Imre K, Pinar E, Oncel S, Calli C, Tatar B, (2008) Predictors of extracapsular spread in lymph node metastasis. European Archives of Oto-Rhino-Laryngology 265: 337-339.
3. Puri SK, Fan CY, Hanna E, (2003) Significance of extracapsular lymph node metastases in patients with head and neck squamous cell carcinoma (Review). Current Opinion in Otolaryngology & Head & Neck Surgery 11: 119-123.
4. Cooper JS, Pajak TF, Forastiere AA, Jacobs J, Campbell BH, et al. (2004) Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350: 1937-1944.
5. Machtay M, Moughan J, Trotti A, Garden AS, Weber RS, et al. (2008) Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol 26: 3582-3589.
6. Garraway LA, Widlund HR, Rubin MA, Getz G, Berger AJ, et al. (2005) Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature 436: 117-122.
7. Zender L, Spector MS, Xue W, Flemming P, Cordon-Cardo C, et al. (2006) Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell 125: 1253-1267.
8. Boehm JS, Zhao JJ, Yao J, Kim SY, Firestein R, et al. (2007) Integrative genomic approaches identify IKBKE as a breast cancer oncogene. Cell 129: 1065-1079.
9. Lastowska M, Viprey V, Santibanez-Koref M, Wappler I, Peters H, et al. (2007) Identification of candidate genes involved in neuroblastoma progression by combining genomic and expression microarrays with survival data. Oncogene 26: 7432-7444.
10. Walker BA, Leone PE, Jenner MW, Li C, Gonzalez D, et al. (2006) Integration of global SNP-based mapping and expression arrays reveals key regions, mechanisms, and genes important in the pathogenesis of multiple myeloma. Blood 108: 1733-1743.
11. Broet P, Camilleri-Broet S, Zhang S, Alifano M, Bangarusamy D, et al. (2009) Prediction of clinical outcome in multiple lung cancer cohorts by integrative genomics: implications for chemotherapy selection. Cancer Res 69: 1055-1062.
12. Marcotte R, Brown KR, Suarez F, Sayad A, Karamboulas K, et al. (2012) Essential gene profiles in breast, pancreatic, and ovarian cancer cells. Cancer Discovery 2: 172-189.
13. Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, et al. (2010) Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363: 24-35.
14. Lin CJ, Grandis JR, Carey TE, Gollin SM, Whiteside TL, et al. (2007) Head and neck squamous cell carcinoma cell lines: established models and rationale for selection (Review). Head & Neck 29: 163-188.
15. Poeta ML, Manola J, Goldwasser MA, Forastiere A, Benoit N, et al. (2007) TP53 mutations and survival in squamous-cell carcinoma of the head and neck. N Engl J Med 357: 2552-2561.
16. Grosse-Wilde A, Voloshanenko O, Bailey SL, Longton GM, Schaefer U, et al. (2008) TRAIL-R deficiency in mice enhances lymph node metastasis without affecting primary tumor development. J Clin Invest 118: 100-110.
17. Chen Y, Chen C, (2008) DNA copy number variation and loss of heterozygosity in relation to recurrence of and survival from head and neck squamous cell carcinoma: a review (Review). Head & Neck 30: 1361-1383.
18. Poplawski AB, Jankowski M, Erickson SW, Diaz dS, Partridge EC, et al. (2010) Frequent genetic differences between matched primary and metastatic breast cancer provide an approach to identification of biomarkers for disease progression. European Journal of Human Genetics 18: 560-568.
19. Malek JA, Mery E, Mahmoud YA, Al Azwani EK, Roger L, et al. (2011) Copy number variation analysis of matched ovarian primary tumors and peritoneal metastasis. PLoS ONE 6: e28561 doi:10.1371/journal.pone.0028561.
20. Yachida S, Jones S, Bozic I, Antal T, Leary R, et al. (2010) Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 467: 1114-1117.
21. Ding L, Ellis MJ, Li S, Larson DE, Chen K, et al. (2010) Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature 464: 999-1005.
22. Mendez E, Lohavanichbutr P, Fan W, Houck JR, Rue TC, et al. (2011) Can a metastatic gene expression profile outperform tumor size as a predictor of occult lymph node metastasis in oral cancer patients? Clin Cancer Res 17: 2466-2473.
23. Mendez E, Fan W, Choi P, Agoff SN, Whipple M, et al. (2007) Tumor-specific genetic expression profile of metastatic oral squamous cell carcinoma. Head & Neck 29: 803-814.
24. Mook S, Knauer M, Bueno-de-Mesquita JM, Retel VP, Wesseling J, et al. (2010) Metastatic potential of T1 breast cancer can be predicted by the 70-gene MammaPrint signature. Annals of Surgical Oncology 17: 1406-1413.
25. van't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, et al. (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415: 530-536.
26. Bruin SC, Klijn C, Liefers GJ, Braaf LM, Joosse SA, et al. (2010) Specific genomic aberrations in primary colorectal cancer are associated with liver metastases. BMC Cancer 10: 662.
27. Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, et al. (2003) A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3: 537-549.
28. Parker F, Maurier F, Delumeau I, Duchesne M, Faucher D, et al. (1996) A Ras-GTPase-activating protein SH3-domain-binding protein. Mol Cell Biol 16: 2561-2569.
29. Kim MM, Wiederschain D, Kennedy D, Hansen E, Yuan ZM, (2007) Modulation of p53 and MDM2 activity by novel interaction with Ras-GAP binding proteins (G3BP). Oncogene 26: 4209-4215.
30. Zhang HZ, Liu JG, Wei YP, Wu C, Cao YK, et al. (2007) Expression of G3BP and RhoC in esophageal squamous carcinoma and their effect on prognosis. World Journal of Gastroenterology 13: 4126-4130.
31. Irvine K, Stirling R, Hume D, Kennedy D, (2004) Rasputin, more promiscuous than ever: a review of G3BP (Review). International Journal of Developmental Biology 48: 1065-1077.
32. Annibaldi A, Dousse A, Martin S, Tazi J, Widmann C, (2011) Revisiting G3BP1 as a RasGAP binding protein: sensitization of tumor cells to chemotherapy by the RasGAP 317-326 sequence does not involve G3BP1. PLoS ONE 6: e29024 doi:10.1371/journal.pone.0029024.
33. Gallouzi IE, Parker F, Chebli K, Maurier F, Labourier E, et al. (1998) A novel phosphorylation-dependent RNase activity of GAP-SH3 binding protein: a potential link between signal transduction and RNA stability. Mol Cell Biol 18: 3956-3965.
34. Atlas R, Behar L, Elliott E, Ginzburg I, (2004) The insulin-like growth factor mRNA binding-protein IMP-1 and the Ras-regulatory protein G3BP associate with tau mRNA and HuD protein in differentiated P19 neuronal cells. J Neurochem 89: 613-626.
35. Arimoto K, Kadowaki N, Ishikawa T, Ichinohe T, Uchiyama T, (2007) FOXP3 expression in peripheral blood rapidly recovers and lacks correlation with the occurrence of graft-versus-host disease after allogeneic stem cell transplantation. Int J Hematol 85: 154-162.
36. Vogelstein B, Lane D, Levine AJ, (2000) Surfing the p53 network. Nature 408: 307-310.
37. Gasco M, Crook T, (2003) The p53 network in head and neck cancer (Review). Oral Oncology 39: 222-231.
38. Kawamura T, Suzuki J, Wang YV, Menendez S, Morera LB, et al. (2009) Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature 460: 1140-1144.
39. Shim JH, Su ZY, Chae JI, Kim DJ, Zhu F, et al. (2010) Epigallocatechin gallate suppresses lung cancer cell growth through Ras-GTPase-activating protein SH3 domain-binding protein 1. Cancer Prevention Research 3: 670-679.
40. Chen C, Mendez E, Houck J, Fan W, Lohavanichbutr P, et al. (2008) Gene expression profiling identifies genes predictive of oral squamous cell carcinoma. Cancer Epidemiology, Biomarkers & Prevention 17: 2152-2162.
41. Xu C, Liu Y, Wang P, Fan W, Rue TC, et al. (2010) Integrative analysis of DNA copy number and gene expression in metastatic oral squamous cell carcinoma identifies genes associated with poor survival. Molecular Cancer 9: 143.
42. Xu C, Houck JR, Fan W, Wang P, Chen Y, et al. (2008) Simultaneous isolation of DNA and RNA from the same cell population obtained by laser capture microdissection for genome and transcriptome profiling. Journal of Molecular Diagnostics 10: 129-134.
43. Zhao LP, Prentice R, Breeden L, (2001) Statistical modeling of large microarray data sets to identify stimulus-response profiles. Proc Natl Acad Sci USA 98: 5631-5636.
44. Thomas JG, Olson JM, Tapscott SJ, Zhao LP, (2001) An efficient and robust statistical modeling approach to discover differentially expressed genes using genomic expression profiles. Genome Res 11: 1227-1236.
45. Lohavanichbutr P, Houck J, Fan W, Yueh B, Mendez E, et al. (2009) Genomewide gene expression profiles of HPV-positive and HPV-negative oropharyngeal cancer: potential implications for treatment choices. Archives of Otolaryngology - Head & Neck Surgery 135: 180-188.
46. Kalbfleisch, J D. and Prentice, R L. (1980) The Statistical Analysis of Failure Time Data. New York: John Wiley & Sons.
47. Gray RJ, (1988) A class of K-sample tests for comparing the cumulative incidence of a competing risk. The Annals of Statistics 16: 1141-1154.
48. Aalen O, (1978) Nonparametric estimation of partial transition probabilities in multiple decrement models. The Annals of Statistics 6: 534-545.
49. Gu X, Song X, Dong Y, Cai H, Walters E, et al. (2008) Vitamin E succinate induces ceramide-mediated apoptosis in head and neck squamous cell carcinoma in vitro and in vivo. Clin Cancer Res 14: 1840-1848.
50. Henson B, Li F, Coatney DD, Carey TE, Mitra RS, et al. (2007) An orthotopic floor-of-mouth model for locoregional growth and spread of human squamous cell carcinoma. Journal of Oral Pathology & Medicine 36: 363-370.